הלוואות ואשראי לטווח ארוך של החברה: Tenax Therapeutics Inc (TENX)

This chart illustrates the price action of Tenax Therapeutics (TENX), where long-term debt stands at 0.00. The business relies on the work of highly paid scientists within a flexible academic environment. Tenax Therapeutics (TENX) develops treatments for severe cardiac pathologies, monetizing scientific discoveries through global patents. A positive brand image is sustained by an innovative approach to treating pulmonary hypertension and the trust of the medical community.

This indicator tracks total credit obligations with maturities exceeding one year, enabling real-time monitoring of financial leverage dynamics. By analyzing the long-term debt of Tenax Therapeutics (TENX), investors can assess the stability of the company, whose capital-intensive cardiovascular drug development model requires significant debt financing until the therapy is commercialized and reaches the low-cost synthesis stage.